Actress and singer Queen Latifah recently took her passion for heart disease awareness live on social media, leading a “Rise Above Heart Failure” panel discussion on Facebook Live on World Heart Day. Novartis sponsored the American Heart Association's effort.
AstraZeneca doesn’t yet have the CV outcomes data for Farxiga that rivals Boehringer Ingelheim and Eli Lilly have for Jardiance. But AstraZeneca isn’t waiting around before it starts scouting other benefits, too.
Novartis has some new Entresto data to add to its case. Researchers crunched numbers to show that the heart failure med is as cost-effective as a generic. The kicker? Using it could save 28,484 lives a year.
Novartis is seeing much faster uptake of heart failure drug Entresto in Europe as payer pushback in the U.S. on Entresto and some other new generation heart drugs are dulling sales in what is usually the best market for new meds.